Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621) |
---|
02/12/2014 | CN102153488B Alpha,beta-diamino acid derivative, synthetic method thereof and application thereof |
02/11/2014 | CA2559187C Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders |
02/11/2014 | CA2501506C Modulation of anxiety through blockade of anandamide hydrolysis |
02/11/2014 | CA2288330C Benzoyl amino acid derivatives useful as inhibitors of protein isoprenyl tranferases |
02/06/2014 | WO2014021166A1 Method for producing blocked isocyanate compound |
02/06/2014 | US20140039200 Organogold complexes and methods for making the same |
02/05/2014 | CN103562182A Process for producing ester compound |
02/05/2014 | CN103562178A Method of manufacturing isoxazoline compound |
02/05/2014 | CN103553972A Method for the preparation of n-substituted carbamic acid ester and method for the preparation of isocyanate using the n-substituted carbamic acid ester |
02/05/2014 | CN103553971A Preparation method for urethane acrylate |
02/05/2014 | CN103553970A Preparation method of carbamate cationic lipid and application of carbamate cationic lipid in medicine or gene delivery |
01/30/2014 | WO2014018913A2 Santacruzamate a compositions and analogs and methods of use |
01/30/2014 | US20140031331 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy |
01/28/2014 | US8637696 Methods for preparing amides and amino acids |
01/28/2014 | US8637534 Fungicide active substance combinations |
01/23/2014 | WO2014014606A1 Carbon dioxide capture and conversion to a carbamate salt and polyurea |
01/23/2014 | WO2014014035A1 Pyrophosphoric acid ester compound, bisphosphoric acid ester compound, and catalyst |
01/23/2014 | US20140024709 Methods of using cycloalkylmethylamine derivatives |
01/22/2014 | EP2686297A2 Use of oligomeric carbodiimides as stabilizers |
01/22/2014 | CN103524381A Synthesis of N-methylmethyl carbamate |
01/17/2014 | CA2820192A1 Enzymatic synthesis process for (7s)-1-(3,4-dimethoxy bicyclo[4.2.0]octa-1,3,5-triene 7-yl) n-methyl methanamine, and application to the synthesis of ivabradine and of its salts |
01/16/2014 | WO2014011220A2 A method of treating androgen receptor (ar)-positive breast cancers with selective androgen receptor modulator (sarms) |
01/16/2014 | US20140018549 Use of d-serine derivatives for the treatment of anxiety disorders |
01/16/2014 | US20140018433 Method of treating androgen receptor (ar) -positive breast cancers with selective androgen receptor modulator (sarms) |
01/15/2014 | EP2684866A1 Compound and method for producing same, as well as method for producing oseltamivir phosphate |
01/15/2014 | EP2684863A1 Iodoarene derivative, method for producing optically active spirolactone compound using same, and method for producing optically active cyclization adduct |
01/15/2014 | CN103508936A Intermediate for preparation of indole benzylamine compound |
01/15/2014 | CN103508918A Cyclobutyl-containing alpha-hydroxy-beta-amino ester compound and preparation method thereof |
01/14/2014 | US8629297 Low-foaming surfactants |
01/09/2014 | WO2014007398A1 Cationic lipid |
01/08/2014 | CN203382698U Methyl carbamate synthesis device |
01/08/2014 | CN103497747A Well cementing slurry lightening agent and preparation method thereof |
01/07/2014 | US8624053 Method to produce a stable dry ionic-bonded creatine α ketoglutarate of high oral absorbability |
01/07/2014 | US8623913 Methods for treating restless legs syndrome |
01/07/2014 | CA2721357C Process for producing isocyanates using diaryl carbonate |
01/03/2014 | WO2014003203A2 Method for producing stereoselective epoxyketone compound |
01/01/2014 | EP2679575A1 Process for producing carbonyl compounds |
01/01/2014 | CN103492446A Novel compound, composition containing said compound, and cured product |
01/01/2014 | CN103491928A Dental material, dental material composition, dental repair material, and cured product |
01/01/2014 | CN103483342A Process for the synthesis of E1 activating enzyme inhibitors |
01/01/2014 | CN103483236A Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentan0ic acid derivatives |
01/01/2014 | CN103483226A Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto |
01/01/2014 | CN103483225A Preparation method for epoxy resin curing agent |
01/01/2014 | CN103483224A Substituted urea alcoholysis method for synthesizing carbamate compounds |
01/01/2014 | CN102600894B Method for preparing loaded organic acid zinc catalyst |
12/31/2013 | US8618124 Heterobifunctional polymeric bioconjugates |
12/31/2013 | CA2552565C Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
12/31/2013 | CA2534298C Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same |
12/27/2013 | WO2013191252A1 Novel polymerizable compound and method for producing same |
12/26/2013 | US20130345423 Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta (g) quinazoline trisodium salt |
12/26/2013 | US20130345386 Polyetheramine Macromonomers Comprising Two Neighboring Hydroxyl Groups And Their Use For Producing Polyurethanes |
12/25/2013 | EP2675783A1 Addition-fragmentation agents |
12/25/2013 | CN103467730A Carbamate compound |
12/25/2013 | CN103467323A Method for preparing beta-unsaturated enamine ester derivative |
12/25/2013 | CN103467225A Method for preparing 1,4-dicarbonyl derivative |
12/25/2013 | CN102702461B Polyurethane with electrochromism performance and preparation method thereof |
12/25/2013 | CN102557989B Ulimorelin intermediate and Ulimorelin preparation method |
12/25/2013 | CN102026964B Process for producing isocyanate using diaryl carbonate |
12/24/2013 | US8614346 Methods and compositions for preparation of amphetamine conjugates and salts thereof |
12/19/2013 | WO2013187480A1 Novel cyclic depsipeptide derivative and pest control agent comprising same |
12/19/2013 | WO2013185435A1 Optical activity axially chiral α-allenic alcohol, synthesis method and use thereof |
12/19/2013 | CA2876387A1 Novel cyclic depsipeptide derivatives and harmful organism control agents comprising the same |
12/18/2013 | CN101213199B Compounds for preparing immunological adjuvant |
12/17/2013 | US8609882 Process for deacetalisation of α aminoacetals |
12/17/2013 | US8609881 Cure accelerators for anaerobic curable compositions |
12/17/2013 | US8609721 Ligands for metabotropic glutamate receptors and inhibitors of NAALADase |
12/12/2013 | WO2013185116A1 Lipids for therapeutic agent delivery formulations |
12/12/2013 | US20130331589 Chemical composition |
12/12/2013 | US20130331568 Acetylene derivatives having mglur 5 antagonistic activity |
12/12/2013 | CA2876148A1 Lipids for therapeutic agent delivery formulations |
12/11/2013 | CN103435516A Modified tripentaerythritol acrylic ester with low viscosity, high reactivity and shrunk volume as well as preparation method thereof |
12/11/2013 | CN103435515A Low-viscosity high-reactivity low-volume-shrinkage modified pentaerythritol acrylate and preparation method thereof |
12/11/2013 | CN103435430A Method for reducing amide compounds |
12/10/2013 | CA2552317C Hcv ns-3 serine protease inhibitors |
12/05/2013 | WO2013180271A1 Prodrug of fluorine-containing amino acid |
12/05/2013 | US20130324717 Copolymerizable methine and anthraquinone compounds and articles containing them |
12/05/2013 | US20130324555 Method of use of pharmaceutical formulations for the treatment of apicomplexan diseases in animals |
12/05/2013 | US20130324539 Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen Fumarate |
12/05/2013 | CA2875080A1 Prodrug of fluorine-containing amino acid |
12/04/2013 | EP2669265A2 Improved method for preparing dipeptidyl peptidase-IV inhibitor and intermediate |
12/04/2013 | CN103420941A 2-methoxyphenyl-dimethylamino formic ether derivative and preparation method and application thereof |
12/04/2013 | CN101553463B New pharmaceutical intermediates in the synthesis of ace- inhibitors and the use thereof |
12/03/2013 | US8598297 Prepolymers made from hydroxymethyl-containing polyester polyols derived from fatty acids |
12/03/2013 | CA2530302C Novel aminobenzophenone compounds |
12/03/2013 | CA2489590C Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
11/28/2013 | US20130317235 Process for the preparation of (1s, 3s, 5s)-2-[2(s)-2-amino-2-(3-hydroxy-1-adamantan-1-yl acetyl]-2-azabicyclo [3.1.0] hexane-3-carbonitrile |
11/28/2013 | US20130317220 NOVEL PROCESSES FOR PREPARING TRIAZOLO[4, 5-d]PYRIMIDINE DERIVATIVES AND INTERMEDIATES THEREOF |
11/28/2013 | US20130317007 Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17 |
11/27/2013 | EP2666766A1 Novel E,E-diene compounds and their use as medicaments and cosmetics |
11/27/2013 | EP2665702A1 Process for the preparation of retigabine |
11/27/2013 | CN103415501A Iodoarene derivative, method for producing optically active spirolactone compound using same, and method for producing optically active cyclization adduct |
11/27/2013 | CN103408465A N,N-disubstituted phenyl methyl valinamide carbamate derivant and application thereof |
11/27/2013 | CN103408464A Low-viscosity high-reactivity low-volume-contraction modified dipentaerythritol acrylate and preparation method thereof |
11/27/2013 | CN102659634B Synthetic method for 2-(N-4-fluorobenzyl) methoxy-acetyl-amino methyl isobutyrate |
11/27/2013 | CN102553642B Catalyst and preparation method for sorafenib intermediate |
11/27/2013 | CN102320993B Method for preparing (R)-2- Boc-amidogen-3-methoxypropionic acid |
11/21/2013 | WO2013173779A1 Process for making amino acid compounds |
11/21/2013 | WO2013172466A1 Method for forming negative pattern, method for producing electronic device, electronic device and actinic ray-sensitive or radiation-sensitive resin composition |
11/21/2013 | WO2013171135A1 Lysin-glutamic acid dipeptide derivatives |
11/20/2013 | EP2664374A1 Lysin-glutamic acid dipeptide derivatives |